Clinical Services & Research

Clinical Services

The Ottawa Blood Disease Centre provides care for patients with blood disorders within 3 major categories:

The Ottawa Blood Disease Centre treats patients from all over the Champlain LHIN. Annually, this includes:

  • Over 30,000 outpatient visits
  • Over 2,000 inpatient stays
  • Over 100 bone marrow transplants
  • Over 1,000 telemedicine visits

In early 2013, the Thrombosis clinic moved from the Civic into our new outpatient space, and consolidated all of our benign Hematology clinics from across the city to Module H at the General Campus. These state of the art and brand new ultrasound, lab and clinic facilities will help us to better serve our patients.


Our physicians and staff are devoted to carrying out practice-changing research. We are continually involved in important clinical studies, and our physician/scientists are world-renowned experts in their fields. Our research is conducted through the research arm of The Ottawa Hospital: the Ottawa Hospital Research Institute (OHRI).


2015/16 was another busy year for our Division. Highlights of our high impact papers from this year include:


Once again, our investigators were granted millions of dollars to advance life-changing research in the area of blood disease. Highlights of grants awarded in 2015-16 include:

  • CIHR Operating Grant: $407,356.¬† Ito C, Perkins, TJ, Sabloff M, Stanford, WL. The role of PCL2/PRC2 in hematopoietic stem cells and leukemia.

  • CIHR Community Development Program Grant: >$5,000,000.¬† Kahn SR, Rodger MA et al. CanVECTOR (Canadian Venous Thromboembolism Clinical Trials and Outcomes Research) Network.

  • CIHR Operating Grant: $187,878.¬†Sheppard D,¬†Tay J, Tinmouth A, Allan DS, Beattie SM, Bredeson C, Fergusson DA, Sabloff M, Thavorn K. Platelet Transfusions in Hematopoietic Stem Cell Transplantation -¬†The PATH Study.

  • CIHR Project Grant: $424,298.¬† Rodger MA, Fergusson DA, Gandara E, Kahn SR, Kearon C, Kovacs MJ, Le Gal G, Ramsay TO, Shivakumar SP, Tagalakis V, Thavom K. StAtins for Venous Even Reduction in Patients with Venous Thromboembolism (SAVER). Top ranking in the 2016 CIHR project competition!

  • Heart & Stroke Foundation Grant-in-Aid: $255,538.¬† Le Gal G, Anderson D, de Wit K, Kahn S, Kearon C, Ramsay T, Rodger MA, Righini M, Shivakumar S, Wells P. Age-adjusted D-dimer cutoff levels to rule out deep vein thrombosis (The ADJUST-DVT Study).

 Honours & Awards

  • Dr. Marc Carrier received the Dr. Michel Chr√©tien Researcher of the Year Award for leading a clinical trial, published in the New England Journal of Medicine, which will save countless thrombosis patients from unnecessary and potentially harmful tests.¬† Rumours are we may soon be boasting about a Hematology ‚Äėthree-peat‚Äô for this award!
  • Dr. Marc Carrier has been recognized as one of two Ottawa research papers on New England Journal of Medicine‚Äôs top 12 list in 2015.¬† Dr. Carrier found that contrary to expectations, CT scanning does not improve cancer detection in people with unexplained blood clots. According to the journal‚Äôs editor, papers chosen for this list represent ‚Äúthe cream of the crop, the dozen studies from 2015 that we think will have the biggest influence on medicine.‚ÄĚ His paper also won the Canadian Hematology Society‚Äôs Paper of the Year award.
  • Dr. Mitch Sabloff was a fan fave performer at this year‚Äôs Dancing with the Docs event!
  • Dr. Melissa Forgie was re-appointed Vice-Dean UGME.
  • Dr. Melissa Forgie was the recipient of the Department of Medicine‚Äôs Jeff Turnbull Health Care Advocacy Award for her work establishing the Ottawa-Shanghai Joint School of Medicine in China.